These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25078137)

  • 41. Potentiation of morphine-induced mechanical antinociception by σ₁ receptor inhibition: role of peripheral σ₁ receptors.
    Sánchez-Fernández C; Nieto FR; González-Cano R; Artacho-Cordón A; Romero L; Montilla-García Á; Zamanillo D; Baeyens JM; Entrena JM; Cobos EJ
    Neuropharmacology; 2013 Jul; 70():348-58. PubMed ID: 23524304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid and adjuvant analgesics: compared and contrasted.
    Khan MI; Walsh D; Brito-Dellan N
    Am J Hosp Palliat Care; 2011 Aug; 28(5):378-83. PubMed ID: 21622486
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intrathecal injection of the sigma(1) receptor antagonist BD1047 blocks both mechanical allodynia and increases in spinal NR1 expression during the induction phase of rodent neuropathic pain.
    Roh DH; Kim HW; Yoon SY; Seo HS; Kwon YB; Kim KW; Han HJ; Beitz AJ; Na HS; Lee JH
    Anesthesiology; 2008 Nov; 109(5):879-89. PubMed ID: 18946301
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transient receptor potential ion channels as targets for the discovery of pain therapeutics.
    Krause JE; Chenard BL; Cortright DN
    Curr Opin Investig Drugs; 2005 Jan; 6(1):48-57. PubMed ID: 15675603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and pharmacological evaluation of a potent and selective σ1 receptor antagonist with high antiallodynic activity.
    Utech T; Köhler J; Buschmann H; Holenz J; Vela JM; Wünsch B
    Arch Pharm (Weinheim); 2011 Jul; 344(7):415-21. PubMed ID: 21598296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Sigma-2 receptor / transmembrane protein 97 (σ2R/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice.
    Quadir SG; Tanino SM; Rohl CD; Sahn JJ; Yao EJ; Cruz LDR; Cottone P; Martin SF; Sabino V
    Neuropharmacology; 2021 Feb; 184():108409. PubMed ID: 33221481
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exogenous melatonin abolishes mechanical allodynia but not thermal hyperalgesia in neuropathic pain. The role of the opioid system and benzodiazepine-gabaergic mechanism.
    Zurowski D; Nowak L; Machowska A; Wordliczek J; Thor PJ
    J Physiol Pharmacol; 2012 Dec; 63(6):641-7. PubMed ID: 23388480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antinociceptive effects and toxicity of morphine-6-O-sulfate sodium salt in rat models of pain.
    Holtman JR; Crooks PA; Johnson-Hardy J; Wala EP
    Eur J Pharmacol; 2010 Dec; 648(1-3):87-94. PubMed ID: 20828549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist.
    McGaraughty S; Jarvis MF
    Drug News Perspect; 2005 Oct; 18(8):501-7. PubMed ID: 16391720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and brain σ1 receptor occupancy of MR309, a selective σ1 receptor antagonist.
    Rabiner EA; Smith K; Bennett C; Rizzo G; Lewis Y; Mundin G; Dooner H; Oksche A
    Br J Clin Pharmacol; 2022 Feb; 88(4):1644-1654. PubMed ID: 34156715
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycine transporter inhibitors as a novel drug discovery strategy for neuropathic pain.
    Dohi T; Morita K; Kitayama T; Motoyama N; Morioka N
    Pharmacol Ther; 2009 Jul; 123(1):54-79. PubMed ID: 19393690
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adjuvant analgesics.
    Knotkova H; Pappagallo M
    Med Clin North Am; 2007 Jan; 91(1):113-24. PubMed ID: 17164107
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The plasticity of the association between mu-opioid receptor and glutamate ionotropic receptor N in opioid analgesic tolerance and neuropathic pain.
    Sánchez-Blázquez P; Rodríguez-Muñoz M; Berrocoso E; Garzón J
    Eur J Pharmacol; 2013 Sep; 716(1-3):94-105. PubMed ID: 23499699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EST64454: a Highly Soluble σ
    Díaz JL; García M; Torrens A; Caamaño AM; Enjo J; Sicre C; Lorente A; Port A; Montero A; Yeste S; Álvarez I; Martín M; Maldonado R; de la Puente B; Vidal-Torres A; Cendán CM; Vela JM; Almansa C
    J Med Chem; 2020 Dec; 63(23):14979-14988. PubMed ID: 33237785
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tephrosia sinapou ethyl acetate extract inhibits inflammatory pain in mice: opioid receptor dependent inhibition of TNFα and IL-1β production.
    Martinez RM; Zarpelon AC; Cardoso RD; Vicentini FT; Georgetti SR; Baracat MM; Andrei CC; Moreira IC; Verri WA; Casagrande R
    Pharm Biol; 2013 Oct; 51(10):1262-71. PubMed ID: 23855752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Peripheral antinociceptive effects of mu- and delta-opioid receptor agonists in NOS2 and NOS1 knockout mice during chronic inflammatory pain.
    Leánez S; Hervera A; Pol O
    Eur J Pharmacol; 2009 Jan; 602(1):41-9. PubMed ID: 19041302
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Role of sigma-1 receptors in paclitaxel-induced neuropathic pain in mice.
    Nieto FR; Cendán CM; Sánchez-Fernández C; Cobos EJ; Entrena JM; Tejada MA; Zamanillo D; Vela JM; Baeyens JM
    J Pain; 2012 Nov; 13(11):1107-21. PubMed ID: 23063344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
    Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
    J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of a Highly Selective Sigma-2 Receptor Ligand, 1-(4-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)butyl)-3-methyl-1H-benzo[d]imidazol-2(3H)-one (CM398), with Drug-Like Properties and Antinociceptive Effects In Vivo.
    Intagliata S; Sharma A; King TI; Mesangeau C; Seminerio M; Chin FT; Wilson LL; Matsumoto RR; McLaughlin JP; Avery BA; McCurdy CR
    AAPS J; 2020 Jul; 22(5):94. PubMed ID: 32691179
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sigma-1 receptor antagonists: promising players in fighting neuropathic pain.
    Linciano P; Rossino G; Listro R; Rossi D; Collina S
    Pharm Pat Anal; 2020 May; 9(3):77-85. PubMed ID: 32539668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.